Clinical Trials Directory

Trials / Unknown

UnknownNCT03413137

Comparing Transperineal to Transrectal MRI-US Fusion Prostate Biopsy

A Prospective Cohort Study Comparing Transperineal to Transrectal MRI-US Fusion Prostate Biopsy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
76 (estimated)
Sponsor
Rabin Medical Center · Academic / Other
Sex
Male
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

This will be a prospective cohort trial that compares transperineal to transrectal MRI-US fusion prostate biopsy

Detailed description

This will be a prospective cohort trial that compares transperineal to transrectal MRI-US fusion prostate biopsy among men. The target population are males that are schedule to undergo MRI-US Fusion prostate biopsy and have an MRI of the prostate. All the pathological samples would be conducted from the area in the prostate that was found as suspicious of malignancy by previous MRI imaging, and defined as region of interest (ROI). First the prostate biopsy will be preformed in a transperineal approach; Then a transrectal approach would be used to sample a few more cores. The primary endpoint will be To compare the detection rate for clinically significant prostate cancer between transperineal vs transrectal mp-MRI-fusion/TRUS biopsies. Additionally, the study aims to determine the accuracy of prostate cancer detection in transperineal vs transrectal mp-MRI-fusion/TRUS biopsies.

Conditions

Interventions

TypeNameDescription
PROCEDURETransperineal mpMRI-US Fusion prostate biopsympMRI-US Fusion prostate biopsy in a transperineal approach to direct the needles towards an area in the prostate that was found as suspicious of malignancy by previous MRI imaging, defined as region of interest (ROI).
PROCEDURETransrectal mpMRI-US Fusion prostate biopsyusing the same system and MRI imaging, a transrectal approach would be used to sample a few more cores from the ROI as defined by the MRI imaging.

Timeline

Start date
2017-12-11
Primary completion
2019-10-01
Completion
2019-10-01
First posted
2018-01-29
Last updated
2018-01-30

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT03413137. Inclusion in this directory is not an endorsement.